> India's Lupin has struck a deal to manufacture TB drugs for GSK Philippines. Report
> Fusion Capital has agreed to buy up to $20 million of GlycoGenesys stock over a 25-month period. Release
> Novelos Therapeutics has gained an end of Phase II meeting with the FDA for its lead drug candidate, the cancer treatment NOV-002. Release
> InvestBio Ventures Partnership has raised $14 million of a planned $20 million investment in The Vaccine Company. Release
> Depomed has completed enrollment for a Phase II clinical trial evaluating the safety and efficacy of its Gabapentin extended release tablets to treat patients with postherpetic neuralgia. Release
> Canada's Cardiome Pharma has completed the acquisition of Artesian Therapeutics. Release
And Finally... The normal ebb and flow of biotech stock prices has been heavily influenced by the entry of hedge funds into the sector, which move rapidly in and out of a stock. Article